Report cover image

Artificial Retina Implant Market Research Report Information by Product (Enzymes, Pharma Products, Bulk Chemicals, and Others), by Application (Bioengineering, Genomics, Vaccine Development, Drug Discovery, Fisheries, Aquaculture, Biofuels, Water Treatmen

Publisher Market Research Future
Published Aug 10, 2024
Length 77 Pages
SKU # RESFT19210281

Description

Artificial Retina Implant Market Research Report Information by Product (Enzymes, Pharma Products, Bulk Chemicals, and Others), by Application (Bioengineering, Genomics, Vaccine Development, Drug Discovery, Fisheries, Aquaculture, Biofuels, Water Treatment Services, and Others), and by End User (Hospitals, Pharmaceutical Companies, Biotechnology Companies, and Others) and by Region (North America, Europe, Asia-Pacific, and Rest of the World) – Industry Forecast till 2032


In 2025, the Artificial Retina Implant Market was estimated to be worth USD 1.51 billion. The Artificial Retina Implant industry is anticipated to experience a compound annual growth rate (CAGR) of 21.22% from USD 1.92 billion in 2026 to USD 7.04 billion by 2032 during the forecast period (2026-2032).

The growing number of startups associated with artificial retina implants and the increasing incidences of age-related macular degeneration (AMD) and retinitis pigmentosa are the factors that are propelling the growth of the global market.

In September 2021, Bionic Vision Technologies, a renowned company in the field of artificial retina technology, announced a significant partnership with Cirtec Medical, a prominent medical technology company based in the United States. The design process will be simplified because of the collaborative effort, which will facilitate joint production for the next iteration of bionic eyes. Bionic Vision Technologies aims to enhance its innovative bionic eye technology to provide a more effective vision solution for individuals with visual impairments by leveraging Cirtec Medical's knowledge base and resources.

Market segment insights
Epiretinal implants, subretinal implants, and suprachoroidal implants comprise the Artificial Retina Market, which is segmented according to product type.
Age-related macular degeneration (AMD) and retinitis pigmentosa comprise the Artificial Retina Market, which is segmented according to its application.

Regional Perspectives
The market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World by region. In 2025, the North American artificial retina implant market held the largest market share, exceeding 50.12%, because of the Food Drug Administration's (FDA) approval of implant products and the growing prevalence of age-related macular degeneration (AMD). For example, Argus II is a product that has been approved by the FDA and is available in the United States.

During the forecast year of 2025–2026, the artificial retina implant market in Europe is expected to experience substantial growth because of the frequent strategic alliances between market participants in order to meet consumer demand. For example, in July 2022, Pixium Vision (France) announced the successful implantation of the first patient in the Netherlands in the Prima System European pivotal trial PRIMAvera. Pixium Vision has since implanted patients in the UK and Germany and established additional clinical sites.

The geriatric population in the Asia-Pacific region is expected to significantly contribute to the growth of the artificial retina implant market during the forecast period, making it the fastest-growing region. For example, the Asia-Pacific Report on Population Ageing 2022 indicates that there were approximately 670 million individuals aged 60 or older in the Asia-Pacific region in 2022. Additionally, it has been projected that the number of individuals in the Asia-Pacific region will double to approximately 1.3 billion by 2050.

Major Players
Bionic Vision Technologies (US), PIXIUM VISION (France), Optobionics (US), Labtician Ophthalmics, Inc (Canada), Vivani Medical Inc. (US), iBIONICS (Canada), LambdaVision, Inc. (US), AXORUS (France), Sensor-Tech Lab (Russia), and Nanovision (US) are among the key companies in the Artificial Retina Implant Market.

Table of Contents

77 Pages
1 Executive Summary
2 Market Introduction
2.1 Definition
2.2 Scope Of The Study
2.3 Research Objective And Assumptions
2.5 Market Structure
3 Research Methodology
3.1 Overview
3.2 Data Flow
3.2.1 Data Mining Process
3.3 Purchased Database:
3.4 Secondary Sources:
3.4.1 Secondary Research Data Flow:
3.5 Primary Research:
3.5.1 Primary Research Data Flow:
3.5.2 Primary Research: Number Of Interviews Conducted
3.6 Approaches For Market Size Estimation:
3.6.1 Revenue Analysis Approach
3.7 Data Forecasting
3.7.1 Data Forecasting Technique
3.8 Data Modeling
3.8.1 Microeconomic Factor Analysis:
3.8.2 Data Modeling:
4 Market Dynamics
4.1 Introduction
4.2 Drivers
4.2.1 Increasing Incidences Of Age-related Macular Degeneration (Amd) And Retinitis Pigmentosa
4.2.2 Growing Number Of Startups Associated With Artificial Retina Implant
4.3 Restraints
4.3.1 High Cost Associated With Artificial Retina Implant Procedures
4.4 Opportunity
4.4.1 Increasing Funding & Investment For Artificial Retina Implant
5 Market Factor Analysis
5.1 Porter's Five Forces Model
5.1.1 Threat Of New Entrants
5.1.2 Bargaining Power Of Suppliers
5.1.3 Threat Of Substitutes
5.1.4 Bargaining Power Of Buyers
5.1.5 Intensity Of Rivalry
5.2 Key Players Developing Brain Implants To Treat Vision Loss
6 Global Artificial Retina Implant Market, By Product Type
6.1 Overview
6.2. Epiretinal Implants
6.3. Subretinal Implants
6.4. Suprachoroidal Implants
7 Global Artificial Retina Implant Market, By Application
7.1 Overview
7.2. Age-related Macular Degeneration (Amd)
7.3. Retinitis Pigmentosa
8 Global Artificial Retina Implant Market, By Region
8.1 Overview
9 Competitive Landscape
9.1 Introduction
9.2 Competitor Dashboard
9.3 Public Players Stock Summary
9.4 Comparative Analysis: Key Players Finanical
9.5 Key Developments & Growth Strategies
9.5.1 Partnership
9.5.2 Expansion
9.5.3 Merger
10 Company Profiles
10.1 Vivani Medical Inc.
10.1.1 Company Overview
10.1.2 Financial Overview
10.1.3 Products Offered
10.1.4 Key Developments
10.1.5 Swot Analysis
10.1.6 Key Strategies
10.2 Ibionics
10.2.1 Company Overview
10.2.2 Financial Overview
10.2.3 Products Offered
10.2.4 Key Developments
10.2.5 Swot Analysis
10.2.6 Key Strategy
10.3 Nanovision Biosciences
10.3.1 Company Overview
10.3.2 Financial Overview
10.3.3 Products Offered
10.3.4 Key Developments
10.3.5 Key Strategy
10.4 Sensor-tech Lab
10.4.1 Company Overview
10.4.2 Financial Overview
10.4.3 Products Offered
10.4.4 Key Developments
10.4.5 Key Strategy
10.5 Labtician Ophthalmics, Inc
10.5.1 Company Overview
10.5.2 Financial Overview
10.5.3 Products Offered
10.5.4 Key Developments
10.5.5 Swot Analysis
10.5.6 Key Strategies
10.6 Optobionics
10.6.1 Company Overview
10.6.2 Financial Overview
10.6.3 Products Offered
10.6.4 Key Developments
10.6.5 Key Strategies
10.7 Lambdavision, Inc.
10.7.1 Company Overview
10.7.2 Financial Overview
10.7.3 Products Offered
10.7.4 Key Developments
10.7.5 Swot Analysis
10.7.6 Key Strategies
10.8 Bionic Vision Technologies
10.8.1 Company Overview
10.8.2 Financial Overview
10.8.3 Products/Services Offered
10.8.4 Key Developments
10.8.5 Key Strategies
10.9 Pixium Vision
10.9.1 Company Overview
10.9.2 Financial Overview
10.9.3 Products Offered
10.9.4 Key Developments
10.9.5 Swot Analysis
10.9.6 Key Strategies
10.10 Axorus
10.10.1 Company Overview
10.10.2 Financial Overview
10.10.3 Products Offered
10.10.4 Key Developments
10.10.5 Key Strategies
10.11 Data Citations
List Of Tables
Table 1 Qfd Modeling For Market Share Assessment
Table 2 Global Artificial Retina Implant Market, By Product Type, 2025–2032 (Usd Thousand)
Table 3 Global Artificial Retina Implant Market, By Application, 2025–2032 (Usd Thousand)
Table 4 Global Artificial Retina Implant Market, 2025–2032 (Usd Thousand)
Table 5 Global Artificial Retina Implant Market, By Region, 2025–2032 (Usd Thousand)
Table 6 Public Players Stock Summary
Table 7 Comparative Analysis: Key Players Finanical
Table 8 Partnership
Table 9 Expansion
Table 10 Merger
Table 11 Vivani Medical, Inc.: Products Offered
Table 12 Vivani Medical, Inc.: Key Developments
Table 13 Ibionics: Products Offered
Table 14 Nanovison: Products Offered
Table 15 Sensor-tech Lab: Products Offered
Table 16 Labtician Ophthalmics, Inc: Products Offered
Table 17 Optobionics: Products Offered
Table 18 Lambdavision, Inc.: Products Offered
Table 19 Bionic Vision Technologies: Products Offered
Table 20 Bionic Vision Technologies: Key Developments
Table 21 Pixium Vision: Products Offered
Table 22 Pixium Vision: Key Developments
Table 23 Axorus: Products Offered
List Of Figures
Figure 1 Global Artificial Retina Implant Market: Structure
Figure 2 Global Artificial Retina Implant Market: Market Growth Factor Analysis
Figure 3 Porter's Five Forces Analysis: Global Artificial Retina Implant Market
Figure 4 Global Artificial Retina Implant Market, Product Type Segment Attractiveness, 2025 & 2032 (Usd Thousand)
Figure 5 Global Artificial Retina Implant Market, By Product Type, 2025 & 2032 (Usd Thousand)
Figure 6 Global Artificial Retina Implant Market Share, By Product Type, 2025 (% Share)
Figure 7 Global Artificial Retina Implant Market, Application Segment Attractiveness, 2025 & 2032 (Usd Thousand)
Figure 8 Global Artificial Retina Implant Market, By Application, 2025 & 2032 (Usd Thousand)
Figure 9 Global Artificial Retina Implant Market, By Region, 2025 & 2032 (Usd Thousand)
Figure 10 Global Artificial Retina Implant Market Share, By Region, 2025 (% Share)
Figure 11 Competitor Dashboard: Artificial Retina Market
Figure 12 Vivani Medical, Inc.: Financial Overview Snapshot
Figure 13 Vivani Medical, Inc.: Swot Analysis
Figure 14 Ibionics: Swot Analysis
Figure 15 Labtician Ophthalmics, Inc: Swot Analysis
Figure 16 Lambdavision, Inc.: Swot Analysis
Figure 17 Pixium Vision: Financial Overview Snapshot
Figure 18 Pixium Vision: Swot Analysis

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us